{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:22:34Z","timestamp":1781104954788,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1999,1]]},"DOI":"10.1007\/bf03345479","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T18:38:57Z","timestamp":1395427137000},"page":"55-63","source":"Crossref","is-referenced-by-count":31,"title":["High prevalence of thyroid dysfunction in adult patients with \u03b2-thalassemia major submitted to amiodarone treatment"],"prefix":"10.1007","volume":"22","author":[{"given":"S.","family":"Mariotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Loviselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Murenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Valentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mandas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Vacquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Balestrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. E.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,22]]},"reference":[{"key":"BF03345479_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00003495-199243010-00007","volume":"43","author":"J Gill","year":"1992","unstructured":"Gill J., Heel R.C., Fitton A. Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias. Drugs 43: 69, 1992.","journal-title":"Drugs"},{"key":"BF03345479_CR2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1172\/JCI108466","volume":"58","author":"A Burger","year":"1976","unstructured":"Burger A., Dinichert D., Nicod P., Jenny M., Lemarchand-Beraud T., Vallotton M.B. Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxine and thyrotropin. A drug influencing peripheral metabolism of thyroid hormone. J. Clin. Invest. 58: 255, 1976.","journal-title":"J. Clin. Invest."},{"key":"BF03345479_CR3","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/0002-8703(83)90008-X","volume":"106","author":"BN Sing","year":"1983","unstructured":"Sing B.N., Nademanee K. Amiodarone and thyroid function: clinical implications during antiarrhythmic therapy. Am. Heart J. 106: 857, 1983.","journal-title":"Am. Heart J."},{"key":"BF03345479_CR4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-101-1-28","volume":"101","author":"E Martino","year":"1984","unstructured":"Martino E., Safran M., Aghini-Lombardi F., Rajatanavin R., Lenziardi M., Fay M., Pacchiarotti A., Aronin N., Macchia E., Haffajee C., Odoguardi L., Love J., Bigalli A., Baschieri L., Pinchera A., Braverman L.E. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann. Intern. Med. 101: 28, 1984.","journal-title":"Ann. Intern. Med."},{"key":"BF03345479_CR5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000180696","volume":"26","author":"E Martino","year":"1987","unstructured":"Martino E., Aghini L.F., Mariotti S., Bartalena L., Braverman L., Pinchera A. Amiodarone: a common source of iodine-induced thyrotoxicosis. Horm. Res. 26: 158, 1987.","journal-title":"Horm. Res."},{"key":"BF03345479_CR6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2265.1987.tb00781.x","volume":"26","author":"E Martino","year":"1987","unstructured":"Martino E., Aghini-Lombardi F., Mariotti S., Bartalena L., Lenziardi M., Ceccarelli C., Bambini G., Safran M., Braverman L.E. Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases. Clin. Endocrinol. (Oxf.) 26: 227, 1987.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03345479_CR7","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/j.1552-4604.1990.tb01861.x","volume":"30","author":"HL Figge","year":"1990","unstructured":"Figge H.L., Figge J. The effects of amiodarone on thyroid hormone function: a review of the physiology and clinical manifestations. J. Clin. Pharmacol. 30: 588, 1990.","journal-title":"J. Clin. Pharmacol."},{"key":"BF03345479_CR8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0002-9343(91)90187-3","volume":"91","author":"MD Trip","year":"1991","unstructured":"Trip M.D., Wiersinga W., Plomp T.A. Incidence, predictability, and pathogenesis of amio-darone-induced thyrotoxicosis and hypothyroidism. Am. J. Med. 91: 507, 1991.","journal-title":"Am. J. Med."},{"key":"BF03345479_CR9","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1001\/archinte.1994.00420230115013","volume":"154","author":"E Martino","year":"1994","unstructured":"Martino E., Aghini-Lombardi F., Bartalena L., Grasso L., Loviselli A., Velluzzi F., Pinchera A., Braverman L.E. Enhanced susceptibility to amiodarone-induced hy-pothyroidism in patients with thyroid autoimmune disease. Arch. Intern. Med. 154: 2722, 1994.","journal-title":"Arch. Intern. Med."},{"key":"BF03345479_CR10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.7326\/0003-4819-126-1-199701010-00009","volume":"126","author":"KJ Harjai","year":"1997","unstructured":"Harjai K.J., Licata A.A. Effects of amiodarone on thyroid function. Ann. Intern. Med. 126: 63, 1997.","journal-title":"Ann. Intern. Med."},{"key":"BF03345479_CR11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF03348098","volume":"9","author":"E Martino","year":"1986","unstructured":"Martino E., Aghini-Lombardi F., Mariotti S., Lenziardi M., Baschieri L., Braverman M.E., Pinchera A. Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium per-chlorate and methimazole. J. Endocrinol. Invest. 9: 201, 1986.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03345479_CR12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/BF03348934","volume":"16","author":"F Aghini-Lombardi","year":"1993","unstructured":"Aghini-Lombardi F., Mariotti S., Fosella P.V., Grasso L., Pinchera A., Braverman L.E., Martino E. Treatment of amiodarone iodine-induced thyrotoxi-cosis with plasmapheresis and methimazole. J. Endocrinol. Invest. 16: 823, 1993.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03345479_CR13","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/bmj.297.6646.456","volume":"297","author":"M Safran","year":"1988","unstructured":"Safran M., Martino E., Aghini-Lombardi F., Bartalena L., Balzano S., Pinchera A., Braverman L.E. Effect of amiodarone on circulating antithyroid antibodies. Br. Med. J. 297: 456, 1988.","journal-title":"Br. Med. J."},{"key":"BF03345479_CR14","first-page":"487","volume":"2","author":"SC Hauser","year":"1993","unstructured":"Hauser S.C. Hemochromatosis and the heart. Heart Dis. Stroke 2: 487, 1993.","journal-title":"Heart Dis. Stroke"},{"key":"BF03345479_CR15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00877096","volume":"8","author":"P Liu","year":"1994","unstructured":"Liu P., Olivieri N. Iron overload cardiomyopathies: new insights into an old isease. Cardiovasc. Drugs Ther. 8: 101, 1994.","journal-title":"Cardiovasc. Drugs Ther."},{"key":"BF03345479_CR16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/adc.58.2.120","volume":"58","author":"AR Sabato","year":"1983","unstructured":"Sabato A.R., De Sanctis V., Atti G., Capra L., Bagni B., Vullo C. Primary hypothyroidism and the low T3 syndrome in thalassemia major. Arch. Dis. Child. 58: 120, 1983.","journal-title":"Arch. Dis. Child."},{"key":"BF03345479_CR17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1530\/acta.0.1070049","volume":"107","author":"L Cavallo","year":"1984","unstructured":"Cavallo L., Licci D., Acquafredda A., Marranzini M., Beccasio R., Scardino M.L., Altomare M., Mastro F., Sisto L., Schettini F. Endocrine involvement in children with beta-thalas-saemia major. Transverse and longitudinal studies. I. Pituitary-thyroidal axis function and its correlation with serum ferritin levels. Acta Endocrinol. (Copenh.) 107: 49, 1984.","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"BF03345479_CR18","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/jcem-58-4-667","volume":"58","author":"A Masala","year":"1984","unstructured":"Masala A., Meloni T., Gallisai D., Alagna S., Rovasio P.P., Rassu S., Milia A.F. Endocrine functioning in multi-transfused prepuper-tal patients with homozygous beta-thalassemia. J. Clin. Endocrinol. Metab. 58: 667, 1984.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03345479_CR19","first-page":"643","volume":"72","author":"V Sanctis De","year":"1988","unstructured":"De Sanctis V., Vullo C., Katz M., Wonke B., Hoffbrand A.V., Bagni B. Hypothalamic-pituitary-gonadal axis in thalassemic patients with secondary amenorrhea. Obstet. Gynecol. 72: 643, 1988.","journal-title":"Obstet. Gynecol."},{"key":"BF03345479_CR20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000205032","volume":"84","author":"S Magro","year":"1990","unstructured":"Magro S., Puzzonia P., Consarino C., Galati M.C., Morgione S., Porcelli D., Grimaldi S., Tancre D., Arcuri V., De Sanctis V., et al. Hypothyroidism in patients with thalassemia syndromes. Acta Haematol. 84: 72, 1990.","journal-title":"Acta Haematol."},{"key":"BF03345479_CR21","first-page":"997","volume":"29","author":"MB Agarwal","year":"1992","unstructured":"Agarwal M.B., Shah S., Vishwanathan C., Rajadhyak-sha G., Bhave A.A., Dube S.R., Billa V., Malkan G., Bajan K. Thyroid dysfunction in multi-transfused iron loaded thalassemia patients. Indian Pediatr. 29: 997, 1992.","journal-title":"Indian Pediatr."},{"key":"BF03345479_CR22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF03348701","volume":"15","author":"L Danesi","year":"1992","unstructured":"Danesi L., Scacchi M., De Martin M., Dubini A., Massaro P., Majolo A.T., Cavagnini F., Polli E.E. Evaluation of hypothalamic-pituitary function in patients with thalassemia major. J. Endocrinol. Invest. 15: 177, 1992.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03345479_CR23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2265.1993.tb00973.x","volume":"38","author":"H Landau","year":"1993","unstructured":"Landau H., Matoth I., Landau C.Z., Goldfarb A., Rachmilewitz E.A., Glaser B. Cross-sectional and longitudinal study of the pituitary-thyroid axis in patients with thalassaemia major. Clin. Endocrinol. (Oxf.) 38: 55, 1993.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03345479_CR24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1651-2227.1994.tb13438.x","volume":"406","author":"S Pantelakis","year":"1994","unstructured":"Pantelakis S. Thyroid disorders and diabetes mellitus as complications of thalassaemia major. Acta Paediatr. (Suppl.) 406: 111, 1994.","journal-title":"Acta Paediatr. (Suppl.)"},{"key":"BF03345479_CR25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2265.1995.tb02683.x","volume":"42","author":"V Sanctis De","year":"1995","unstructured":"De Sanctis V., Pintor C., Gamberini M.R., Ughi M., Pinamonti A., Aliquo M.C., Anastasi S., And\u00f2 S., Brancati C., Bruno M.A., et al. Multicentre study on prevalence of endocrine complications in thalassaemia major: Italian working group on endocrine complications in non-endocrine diseases. Clin. Endocrinol. (Oxf.) 42: 581, 1995.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03345479_CR26","first-page":"227","volume":"15","author":"M Simone De","year":"1995","unstructured":"De Simone M., Olioso P., Di Bartolomeo P., Di Girolamo G., Farello G., Palumbo M., Papalinetti G., Bavaro P., Angrilli F., Torlontano G., et al. Growth and endocrine function following bone marrow transplantation for thalassemia. Bone Marrow Transplant. 15: 227, 1995.","journal-title":"Bone Marrow Transplant."},{"key":"BF03345479_CR27","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/oxfordjournals.humrep.a019515","volume":"11","author":"J Papadimas","year":"1996","unstructured":"Papadimas J., Mandala E., Pados G., Kokkas B., Georgiadis G., Tarlatzis B., Bontis J., Sinakos Z., Mantalenakis S. Pituitary-testicular axis in men with beta-thalassaemia major. Hum. Reprod. 11: 1900, 1996.","journal-title":"Hum. Reprod."},{"key":"BF03345479_CR28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2265.1984.tb03440.x","volume":"20","author":"C Phanekos","year":"1984","unstructured":"Phanekos C., Kamerou A., Pipis P., Constantoulakis M., Lasaridis J., Detsi S., Politou K. Thyroid function in patients with homozygous \u03b2-thalassaemia. Clin. Endocrinol. (Oxf.) 20: 445, 1984.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03345479_CR29","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/BF03349681","volume":"17","author":"E Martino","year":"1994","unstructured":"Martino E., Loviselli A., Velluzzi F., Murtas M.L., Carta M., Lampis M., Murru R., Mastinu A., Arba M.L., Sica V., Taberlet A., Grasso L., Maccherini D., Antonangeli L., Aghini-Lombardi F. Endemic goiter and thyroid function in Central-Southern Sardinia: Report on an extensive epidemio-logical survey. J. Endocrinol. Invest. 17: 653, 1994.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03345479_CR30","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archinte.1993.00410070068010","volume":"153","author":"E Roti","year":"1993","unstructured":"Roti E., Minelli R., Gardini E., Bianconi L., Braverman L.E. Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid. Arch. Intern. Med. 153: 886, 1993.","journal-title":"Arch. Intern. Med."},{"key":"BF03345479_CR31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/thy.1995.5.177","volume":"5","author":"MD Brennan","year":"1995","unstructured":"Brennan M.D., Erickson D.Z., Carney J.A., Bahn R.S. Nongoitrous (Type I) amiodarone-associated thyro-toxicosis: Evidence of follicular disruption in vitro and in vivo. Thyroid 5: 177, 1995.","journal-title":"Thyroid"},{"key":"BF03345479_CR32","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM196910092811504","volume":"281","author":"LE Braverman","year":"1969","unstructured":"Braverman L.E., Woeber K.A., Ingbar S.H. Induction of myxedema by iodide in patients euthy-roid after radioiodine or surgical treatment of diffuse toxic goiter. N. Engl. J. Med. 281: 816, 1969.","journal-title":"N. Engl. J. Med."},{"key":"BF03345479_CR33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1210\/jcem-32-4-515","volume":"32","author":"LE Braverman","year":"1971","unstructured":"Braverman L.E., Ingbar S.H., Vagenakis A.G., Adams L., Maloof F. Enhanced susceptibility to iodide myxedema in patients with Hashimoto\u2019s disease. J. Clin. Endocrinol. Metab. 32: 515, 1971.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03345479_CR34","first-page":"29","volume":"1","author":"LE Braverman","year":"1990","unstructured":"Braverman L.E. Iodine induced thyroid disease. Acta Med. Austriaca 1: 29, 1990.","journal-title":"Acta Med. Austriaca"},{"key":"BF03345479_CR35","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1210\/jcem-73-5-958","volume":"73","author":"E Roti","year":"1991","unstructured":"Roti E., Minelli R., Gardini E., Bianconi L., Neri T., Gavaruzzi G., Ugolotti G., Salvo D., Braverman L.E. Impaired intrathyroidal iodine organification and iodine-induced hypothyroidism in euthyroid women with a previous episode of postpartum thyroiditis. J. Clin. Endocrinol. Metab. 73: 958, 1991.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03345479_CR36","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/BF03348819","volume":"15","author":"R Minelli","year":"1992","unstructured":"Minelli R., Gardini E., Bianconi L., Salvi M., Roti E. Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism. The subsequent phases of thyroid function in a patient chronically treated with amiodarone. J. Endocrinol. Invest. 15: 853, 1992.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03345479_CR37","first-page":"215","volume-title":"Proceedings 77th Annual Meeting of the Endocrine Society","author":"T Alexandrides","year":"1995","unstructured":"Alexandrides T., Pagoni C., Gergopoulos N., Makri M., Vagenakis A. Subclinical hypothyroidism in patients with \u03b2-thalasse-mia major and normal thyroid function after iodine treatment. Proceedings 77th Annual Meeting of the Endocrine Society: 215, 1995."},{"key":"BF03345479_CR38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0889-8529(18)30482-1","volume":"16","author":"M Safran","year":"1987","unstructured":"Safran M., Paul T.L., Roti E., Braverman L.E. Environmental factors affecting autoimmune thyroid disease. Endocrinol. Metab. North Am. 16: 327, 1987.","journal-title":"Endocrinol. Metab. North Am."},{"key":"BF03345479_CR39","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF03350159","volume":"11","author":"A Loviselli","year":"1988","unstructured":"Loviselli A., Bartalena L., Balzano S., Aghini L.F., Sica V., Pilosu R., Petrini L., Giannessi G., Buratti L., Martino E. Absence of serum thyroid hormone autoantibodies in patients chronically treated with amiodarone. J. Endocrinol. Invest. 11: 323, 1988.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03345479_CR40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3109\/08830189209061789","volume":"9","author":"TR Brown","year":"1992","unstructured":"Brown T.R., Bagchi N. The role of iodine in the development of autoimmune thyroiditis. Int. Rev. Immunol. 9: 167, 1992.","journal-title":"Int. Rev. Immunol."},{"key":"BF03345479_CR41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/08916939209014636","volume":"13","author":"RS Sundick","year":"1992","unstructured":"Sundick R.S., Bagchi N., Brown T.R. The role of iodine in thyroid autoimmunity: from chickens to humans: a review. Autoimmunity 13: 61, 1992.","journal-title":"Autoimmunity"},{"key":"BF03345479_CR42","first-page":"423","volume":"78","author":"L Bartalena","year":"1994","unstructured":"Bartalena L., Grasso L., Brogioni S., Aghini-Lombardi F., Braverman L.E., Martino E. Serum interleukin-6 in amiodarone-induced thyro-toxicosis. J. Clin. Endocrinol. Metab. 78: 423, 1994.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03345479_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-198301000-00001","volume":"62","author":"JE Fradkin","year":"1983","unstructured":"Fradkin J.E., Wolff J. Iodide-induced thyrotoxicosis. Medicine (Baltimore) 62: 1, 1983.","journal-title":"Medicine (Baltimore)"},{"key":"BF03345479_CR44","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0002-9343(90)90531-H","volume":"88","author":"I Klein","year":"1990","unstructured":"Klein I. Thyroid hormone and the cardiovascular system. Am. J. Med. 88: 631, 1990.","journal-title":"Am. J. Med."},{"key":"BF03345479_CR45","first-page":"332","volume":"77","author":"PW Ladenson","year":"1993","unstructured":"Ladenson P.W. Editorial: thyrotoxicosis and the heart: something old and something new. J. Clin. Endocrinol. Metab. 77: 332, 1993.","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03345479.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03345479\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03345479","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T19:50:12Z","timestamp":1565293812000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03345479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,1]]}},"alternative-id":["BF03345479"],"URL":"https:\/\/doi.org\/10.1007\/bf03345479","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}